CCCC
C4 Therapeutics, Inc.
-0.03 (-0.87%)3.42USD588K成交股數421M市值–本益比(近四季)12.0股價營收比+2.8%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 07-13 | REYNO LEONARD | Chief Medical Officer | F 繳稅扣股 | 7.4K | 4.06 | 30K | 372K | SEC |
| 2026-07-10 | 07-13 | REYNO LEONARD | Chief Medical Officer | M 選擇權執行 | 15.3K | – | – | 380K | SEC |
| 2026-07-01 | 07-02 | Anderson Kenneth Carl | Director | A 獲配股票 | 2.6K | 4.34 | 12K | 72.0K | SEC |
| 2026-07-01 | 07-02 | GROGAN DONNA ROY | Director | A 獲配股票 | 3.3K | 4.34 | 14K | 74.9K | SEC |
| 2026-06-01 | 06-04 | Anderson Kenneth Carl | Director | M 選擇權執行 | 1.1K | 2.11 | 2K | 69.3K | SEC |
| 2026-04-01 | 04-03 | Anderson Kenneth Carl | Director | A 獲配股票 | 4.3K | 2.70 | 11K | 68.2K | SEC |
| 2026-04-01 | 04-03 | GROGAN DONNA ROY | Director | A 獲配股票 | 5.4K | 2.70 | 14K | 71.5K | SEC |
| 2026-02-15 | 02-18 | Hirsch Andrew | President & CEO | F 繳稅扣股 | 9.1K | 1.89 | 17K | 1.1M | SEC |
| 2026-02-15 | 02-18 | Hirsch Andrew | President & CEO | M 選擇權執行 | 20.4K | – | – | 1.1M | SEC |
| 2026-02-14 | 02-18 | Adams Kendra | Chief Financial Officer | M 選擇權執行 | 30.9K | – | – | 400K | SEC |
| 2026-02-14 | 02-18 | Adams Kendra | Chief Financial Officer | F 繳稅扣股 | 15.4K | 1.89 | 29K | 385K | SEC |
| 2026-02-14 | 02-18 | Mahaney Paige | Chief Scientific Officer | M 選擇權執行 | 7.0K | – | – | 339K | SEC |
| 2026-02-14 | 02-18 | Mahaney Paige | Chief Scientific Officer | F 繳稅扣股 | 2.4K | 1.89 | 5K | 337K | SEC |
| 2026-02-14 | 02-18 | Schick Kelly | Chief People Officer | F 繳稅扣股 | 7.3K | 1.89 | 14K | 300K | SEC |
| 2026-02-14 | 02-18 | Mossler Mark | Chief Accounting Officer | F 繳稅扣股 | 3.3K | 1.89 | 6K | 71.9K | SEC |
| 2026-02-14 | 02-18 | Hirsch Andrew | President & CEO | M 選擇權執行 | 81.7K | – | – | 1.1M | SEC |
| 2026-02-14 | 02-18 | Mossler Mark | Chief Accounting Officer | M 選擇權執行 | 9.4K | – | – | 75.2K | SEC |
| 2026-02-14 | 02-18 | Boyle Scott N | Chief Business Officer | M 選擇權執行 | 20.9K | – | – | 306K | SEC |
| 2026-02-14 | 02-18 | REYNO LEONARD | Chief Medical Officer | M 選擇權執行 | 30.9K | – | – | 396K | SEC |
| 2026-02-14 | 02-18 | Hirsch Andrew | President & CEO | F 繳稅扣股 | 39.2K | 1.89 | 74K | 1.1M | SEC |
| 2026-02-14 | 02-18 | Boyle Scott N | Chief Business Officer | F 繳稅扣股 | 7.3K | 1.89 | 14K | 299K | SEC |
| 2026-02-14 | 02-18 | REYNO LEONARD | Chief Medical Officer | F 繳稅扣股 | 16.6K | 1.89 | 31K | 380K | SEC |
| 2026-02-14 | 02-18 | Schick Kelly | Chief People Officer | M 選擇權執行 | 20.9K | – | – | 307K | SEC |
| 2026-02-13 | 02-18 | Mahaney Paige | Chief Scientific Officer | A 獲配股票 | 240K | – | – | 339K | SEC |
| 2026-02-13 | 02-18 | Schick Kelly | Chief People Officer | F 繳稅扣股 | 1.7K | 1.89 | 3K | 307K | SEC |
| 2026-02-13 | 02-18 | Adams Kendra | Chief Financial Officer | M 選擇權執行 | 3.8K | – | – | 402K | SEC |
| 2026-02-13 | 02-18 | Adams Kendra | Chief Financial Officer | F 繳稅扣股 | 1.9K | 1.89 | 4K | 400K | SEC |
| 2026-02-13 | 02-18 | Schick Kelly | Chief People Officer | M 選擇權執行 | 5.0K | – | – | 309K | SEC |
| 2026-02-13 | 02-18 | Schick Kelly | Chief People Officer | A 獲配股票 | 200K | – | – | 309K | SEC |
| 2026-02-13 | 02-18 | REYNO LEONARD | Chief Medical Officer | A 獲配股票 | 240K | – | – | 396K | SEC |
| 2026-02-13 | 02-18 | Adams Kendra | Chief Financial Officer | A 獲配股票 | 240K | – | – | 402K | SEC |
| 2026-02-13 | 02-18 | Mossler Mark | Chief Accounting Officer | A 獲配股票 | 57.0K | – | – | 75.2K | SEC |
| 2026-02-13 | 02-18 | Boyle Scott N | Chief Business Officer | M 選擇權執行 | 5.0K | – | – | 308K | SEC |
| 2026-02-13 | 02-18 | Boyle Scott N | Chief Business Officer | F 繳稅扣股 | 1.7K | 1.89 | 3K | 306K | SEC |
| 2026-02-13 | 02-18 | Boyle Scott N | Chief Business Officer | A 獲配股票 | 200K | – | – | 308K | SEC |
| 2026-02-13 | 02-18 | Hirsch Andrew | President & CEO | A 獲配股票 | 700K | – | – | 1.1M | SEC |
| 2026-01-16 | 01-16 | REYNO LEONARD | Chief Medical Officer | S 公開市場賣出 | 10.0K | 2.22 | 22K | 156K | SEC |
| 2026-01-02 | 01-05 | Anderson Kenneth Carl | Director | A 獲配股票 | 6.0K | 1.93 | 11K | 147K | SEC |
| 2026-01-02 | 01-05 | GROGAN DONNA ROY | Director | A 獲配股票 | 7.5K | 1.93 | 15K | 66.1K | SEC |
| 2025-10-28 | 10-30 | Mahaney Paige | Chief Scientific Officer | M 選擇權執行 | 19.2K | – | – | 105K | SEC |
| 2025-10-28 | 10-30 | Mahaney Paige | Chief Scientific Officer | F 繳稅扣股 | 5.6K | 2.58 | 15K | 99.4K | SEC |
| 2025-10-01 | 10-03 | Anderson Kenneth Carl | Director | A 獲配股票 | 5.3K | 2.15 | 12K | 141K | SEC |
| 2025-10-01 | 10-03 | GROGAN DONNA ROY | Director | A 獲配股票 | 6.7K | 2.15 | 14K | 58.6K | SEC |
| 2025-09-18 | 09-19 | Adams Kendra | Chief Financial Officer | F 繳稅扣股 | 2.8K | 3.32 | 9K | 162K | SEC |
| 2025-09-18 | 09-19 | Adams Kendra | Chief Financial Officer | M 選擇權執行 | 6.3K | – | – | 165K | SEC |
| 2025-07-10 | 07-15 | REYNO LEONARD | Chief Medical Officer | M 選擇權執行 | 15.3K | – | – | 174K | SEC |
| 2025-07-10 | 07-15 | REYNO LEONARD | Chief Medical Officer | F 繳稅扣股 | 7.4K | 1.99 | 15K | 166K | SEC |
| 2025-07-10 | 07-14 | REYNO LEONARD | Chief Medical Officer | F 繳稅扣股 | 7.4K | 1.99 | 15K | 166K | SEC |
| 2025-07-01 | 07-02 | GROGAN DONNA ROY | Director | A 獲配股票 | 9.6K | 1.51 | 15K | 51.9K | SEC |
| 2025-07-01 | 07-02 | Anderson Kenneth Carl | Director | A 獲配股票 | 7.6K | 1.51 | 12K | 135K | SEC |
| 2025-04-01 | 04-03 | GROGAN DONNA ROY | Director | A 獲配股票 | 9.6K | 1.44 | 14K | 42.3K | SEC |
| 2025-04-01 | 04-03 | Anderson Kenneth Carl | Director | A 獲配股票 | 7.8K | 1.44 | 11K | 128K | SEC |
| 2025-02-18 | 02-18 | Boyle Scott N | Chief Business Officer | S 公開市場賣出(10b5-1) | 669 | 3.15 | 2K | 108K | SEC |
| 2025-02-15 | 02-18 | Hirsch Andrew | President & CEO | F 繳稅扣股 | 9.4K | 3.18 | 30K | 423K | SEC |
| 2025-02-14 | 02-18 | Schick Kelly | Chief People Officer | A 獲配股票 | 56.5K | – | – | 111K | SEC |
| 2025-02-14 | 02-18 | Schick Kelly | Chief People Officer | F 繳稅扣股 | 2.4K | 3.18 | 8K | 109K | SEC |
| 2025-02-14 | 02-18 | REYNO LEONARD | Chief Medical Officer | A 獲配股票 | 87.1K | – | – | 179K | SEC |
| 2025-02-14 | 02-18 | Adams Kendra | Chief Financial Officer | F 繳稅扣股 | 4.6K | 3.18 | 14K | 165K | SEC |
| 2025-02-14 | 02-18 | Adams Kendra | Chief Financial Officer | A 獲配股票 | 87.1K | – | – | 170K | SEC |
| 2025-02-14 | 02-18 | REYNO LEONARD | Chief Medical Officer | F 繳稅扣股 | 5.1K | 3.18 | 16K | 174K | SEC |
| 2025-02-14 | 02-18 | Mahaney Paige | Chief Scientific Officer | A 獲配股票 | 28.2K | – | – | 105K | SEC |
| 2025-02-14 | 02-18 | Mossler Mark | Chief Accounting Officer | F 繳稅扣股 | 1.6K | 3.18 | 5K | 18.2K | SEC |
| 2025-02-14 | 02-18 | Hirsch Andrew | President & CEO | F 繳稅扣股 | 12.8K | 3.18 | 41K | 433K | SEC |
| 2025-02-14 | 02-18 | Boyle Scott N | Chief Business Officer | A 獲配股票 | 56.5K | – | – | 111K | SEC |
| 2025-02-14 | 02-18 | Hirsch Andrew | President & CEO | A 獲配股票 | 224K | – | – | 445K | SEC |
| 2025-02-14 | 02-18 | Siegel Jolie | Chief Legal Officer | F 繳稅扣股 | 2.9K | 3.18 | 9K | 108K | SEC |
| 2025-02-14 | 02-18 | Siegel Jolie | Chief Legal Officer | A 獲配股票 | 56.5K | – | – | 111K | SEC |
| 2025-02-14 | 02-18 | Boyle Scott N | Chief Business Officer | F 繳稅扣股 | 2.4K | 3.18 | 8K | 108K | SEC |
| 2025-02-14 | 02-18 | Boyle Scott N | Chief Business Officer | S 公開市場賣出(10b5-1) | 490 | 3.15 | 2K | 111K | SEC |
| 2025-02-13 | 02-18 | Boyle Scott N | Chief Business Officer | F 繳稅扣股 | 1.7K | 3.20 | 6K | 54.8K | SEC |
| 2025-02-13 | 02-18 | Schick Kelly | Chief People Officer | F 繳稅扣股 | 1.7K | 3.20 | 6K | 54.8K | SEC |
| 2025-02-13 | 02-18 | Adams Kendra | Chief Financial Officer | F 繳稅扣股 | 1.9K | 3.20 | 6K | 82.6K | SEC |
| 2025-02-13 | 02-18 | Siegel Jolie | Chief Legal Officer | F 繳稅扣股 | 2.1K | 3.20 | 7K | 54.4K | SEC |
| 2025-01-02 | 01-03 | GROGAN DONNA ROY | Director | A 獲配股票 | 3.8K | 3.66 | 14K | 32.7K | SEC |
| 2025-01-02 | 01-03 | Anderson Kenneth Carl | Director | A 獲配股票 | 3.1K | 3.66 | 11K | 120K | SEC |
| 2024-11-07 | 11-12 | Schick Kelly | Chief People Officer | M 選擇權執行 | 3.8K | – | – | 57.6K | SEC |
| 2024-11-07 | 11-12 | Siegel Jolie | Chief Legal Officer | F 繳稅扣股 | 1.1K | 6.04 | 7K | 56.5K | SEC |
| 2024-11-07 | 11-12 | Siegel Jolie | Chief Legal Officer | M 選擇權執行 | 3.8K | – | – | 57.6K | SEC |
| 2024-11-07 | 11-12 | Hirsch Andrew | President & CEO | F 繳稅扣股 | 5.5K | 6.04 | 34K | 222K | SEC |
| 2024-11-07 | 11-12 | Hirsch Andrew | President & CEO | M 選擇權執行 | 12.5K | – | – | 227K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MORGAN STANLEY | 8.9M | 41.4M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 8.0M | 37.4M | 新進 | 新進 |
| BlackRock, Inc. | 7.9M | 36.9M | 新進 | 新進 |
| Lynx1 Capital Management LP | 7.3M | 34.2M | 新進 | 新進 |
| Squadron Capital Management LLC | 7.2M | 33.6M | 新進 | 新進 |
| Bain Capital Life Sciences Investors, LLC | 7.2M | 33.5M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 4.7M | 20.7M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | 20.6M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 4.2M | 19.6M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 3.5M | 16.5M | 新進 | 新進 |
| WASATCH ADVISORS LP | 3.5M | 16.5M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 3.5M | 16.2M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 3.4M | 15.8M | 新進 | 新進 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3.0M | 14.2M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 2.7M | 12.4M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 11.8M | 新進 | 新進 |
| Ikarian Capital, LLC | 2.4M | 11.4M | 新進 | 新進 |
| STATE STREET CORP | 2.1M | 9.9M | 新進 | 新進 |
| Candriam S.C.A. | 1.8M | 8.4M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 1.7M | 8.1M | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.7M | 8.1M | 新進 | 新進 |
| Patient Square Capital LP | 1.6M | 7.5M | 新進 | 新進 |
| HighVista Strategies LLC | 1.3M | 6.3M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.2M | 5.6M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.2M | 5.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 148 +25 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 148 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 118M · 95.6% |
| 合計季末市值 | 538M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 37.4M |
|---|---|
| 與上期比 | +9.9% |
| 佔流通股數 | 30.41% |
| 日均成交量 | 2.2M |
| 回補天數 | 16.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 37.4M | +9.9% | 30.41% | 2.2M | 16.7 |
| 2026-08-14 | 34.0M | +11.9% | 27.68% | 2.4M | 13.9 |
| 2026-07-31 | 30.4M | +27.8% | 24.73% | 2.7M | 11.1 |
| 2026-07-15 | 23.8M | -4.7% | 19.36% | 3.6M | 6.7 |
| 2026-06-30 | 25.0M | +12.4% | 20.32% | 4.8M | 5.3 |
| 2026-06-15 | 22.2M | +2.8% | 18.08% | 2.3M | 9.5 |
| 2026-05-29 | 21.7M | +1.9% | 17.60% | 2.3M | 9.4 |
| 2026-05-15 | 21.3M | +0.9% | 17.28% | 3.7M | 5.8 |
| 2026-04-30 | 21.1M | +0.1% | 17.11% | 1.9M | 10.9 |
| 2026-04-15 | 21.0M | +30.2% | 17.10% | 4.2M | 5.1 |
| 2026-03-31 | 16.2M | +19.4% | 13.13% | 1.9M | 8.4 |
| 2026-03-13 | 13.5M | +58.8% | 11.00% | 3.6M | 3.7 |
| 2026-02-27 | 8.5M | +19.6% | 6.93% | 2.5M | 3.4 |
| 2026-02-13 | 7.1M | -1.2% | 5.79% | 869K | 8.2 |
| 2026-01-30 | 7.2M | -2.3% | 5.86% | 1.9M | 3.8 |
| 2026-01-15 | 7.4M | +1.4% | 6.00% | 1.3M | 5.8 |
| 2025-12-31 | 7.3M | +1.5% | 5.92% | 2.1M | 3.5 |
| 2025-12-15 | 7.2M | +28.4% | 5.83% | 1.6M | 4.4 |
| 2025-11-28 | 5.6M | +15.3% | 4.54% | 1.2M | 4.8 |
| 2025-11-14 | 4.8M | +0.8% | 3.94% | 1.7M | 2.9 |
| 2025-10-31 | 4.8M | +20.7% | 3.91% | 2.5M | 1.9 |
| 2025-10-15 | 4.0M | +13.2% | 3.24% | 2.7M | 1.5 |
| 2025-09-30 | 3.5M | -0.6% | 2.86% | 1.9M | 1.9 |
| 2025-09-15 | 3.5M | -6.4% | 2.88% | 1.6M | 2.2 |
| 2025-08-29 | 3.8M | -8.8% | 3.07% | 1.1M | 3.3 |
| 2025-08-15 | 4.1M | -11.0% | 3.37% | 2.0M | 2.1 |